Terms: = Prostate cancer AND BCL3, P20749, 602, ENSG00000069399, D19S37, BCL4 AND Treatment
42 results:
1. Bone-Modifying Agents in Patients With High-Risk Metastatic Castration-Sensitive prostate cancer Treated With Abiraterone Acetate.
Fukuokaya W; Mori K; Urabe F; Igarashi T; Yanagisawa T; Tsuzuki S; Honda M; Miki K; Kimura T
JAMA Netw Open; 2024 Mar; 7(3):e242467. PubMed ID: 38488793
[TBL] [Abstract] [Full Text] [Related]
2. The Efficacy of Ketoconazole Containing Regimens in Castration-Resistant prostate cancer: A Systematic Review and Meta-Analysis.
Rehman OU; Nadeem ZA; Fatima E; Akram U; Imran H; Husnain A; Nadeem A; Rasheed W
Clin Genitourin Cancer; 2024 Apr; 22(2):483-490.e5. PubMed ID: 38296679
[TBL] [Abstract] [Full Text] [Related]
3. Discovery of a small molecule that inhibits Bcl-3-mediated cyclin D1 expression in melanoma cells.
Saamarthy K; Ahlqvist K; Daams R; Balagunaseelan N; Rinaldo-Matthis A; Kazi JU; Sime W; Massoumi R
BMC Cancer; 2024 Jan; 24(1):103. PubMed ID: 38238702
[TBL] [Abstract] [Full Text] [Related]
4. Trends in Utilization and Medicare Spending on Short-Course Radiation Therapy for Breast and prostate cancer: An Episode-Based Analysis From 2015 to 2019.
Patel TA; Jain B; Vapiwala N; Chino F; Tringale KR; Mahal BA; Yamoah K; McBride SN; Lam MB; Hubbard A; Nguyen PL; Dee EC
Int J Radiat Oncol Biol Phys; 2024 May; 119(1):17-22. PubMed ID: 38072324
[TBL] [Abstract] [Full Text] [Related]
5. Charcot neuroarthropathy in persons with diabetes: It's time for a paradigm shift in our thinking.
Wukich DK; Frykberg RG; Kavarthapu V
Diabetes Metab Res Rev; 2024 Mar; 40(3):e3754. PubMed ID: 38069459
[TBL] [Abstract] [Full Text] [Related]
6. A cross-sectional study on Chinese oncology nurses' knowledge of bone health among cancer patients.
Shan J; Lv S; Chen L; Li T; Li J; Wang S; Zhang C
Support Care Cancer; 2023 Aug; 31(8):501. PubMed ID: 37526757
[TBL] [Abstract] [Full Text] [Related]
7. Germline Genetic Testing After cancer Diagnosis.
Kurian AW; Abrahamse P; Furgal A; Ward KC; Hamilton AS; Hodan R; Tocco R; Liu L; Berek JS; Hoang L; Yussuf A; Susswein L; Esplin ED; Slavin TP; Gomez SL; Hofer TP; Katz SJ
JAMA; 2023 Jul; 330(1):43-51. PubMed ID: 37276540
[TBL] [Abstract] [Full Text] [Related]
8. Predictive Factors for Gleason Score Upgrading in Patients with prostate cancer after Radical prostatectomy: A Systematic Review and Meta-Analysis.
Wang Y; Chen X; Liu K; Liu R; Li L; Yin C; Song P
Urol Int; 2023; 107(5):460-479. PubMed ID: 36990065
[TBL] [Abstract] [Full Text] [Related]
9. The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial.
Pollack A; Karrison TG; Balogh AG; Gomella LG; Low DA; Bruner DW; Wefel JS; Martin AG; Michalski JM; Angyalfi SJ; Lukka H; Faria SL; Rodrigues GB; Beauchemin MC; Lee RJ; Seaward SA; Allen AM; Monitto DC; Seiferheld W; Sartor O; Feng F; Sandler HM
Lancet; 2022 May; 399(10338):1886-1901. PubMed ID: 35569466
[TBL] [Abstract] [Full Text] [Related]
10. Ketoconazole for the treatment of Docetaxel-Naïve Metastatic Castration-Resistant prostate cancer (mCRPC): A Systematic Review.
Tresnanda RI; Pramod SV; Safriadi F
Asian Pac J Cancer Prev; 2021 Oct; 22(10):3101-3107. PubMed ID: 34710984
[TBL] [Abstract] [Full Text] [Related]
11. Real-world Cardiovascular Outcomes Associated With Degarelix vs Leuprolide for prostate cancer treatment.
Wallach JD; Deng Y; McCoy RG; Dhruva SS; Herrin J; Berkowitz A; Polley EC; Quinto K; Gandotra C; Crown W; Noseworthy P; Yao X; Shah ND; Ross JS; Lyon TD
JAMA Netw Open; 2021 Oct; 4(10):e2130587. PubMed ID: 34677594
[TBL] [Abstract] [Full Text] [Related]
12. PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine.
Baldelli E; Hodge KA; Bellezza G; Shah NJ; Gambara G; Sidoni A; Mandarano M; Ruhunusiri C; Dunetz B; Abu-Khalaf M; Wulfkuhle J; Gallagher RI; Liotta L; de Bono J; Mehra N; Riisnaes R; Ravaggi A; Odicino F; Sereni MI; Blackburn M; Zupa A; Improta G; Demsko P; Crino' L; Ludovini V; Giaccone G; Petricoin EF; Pierobon M
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34620701
[TBL] [Abstract] [Full Text] [Related]
13. Posterior musculofascial reconstruction in robotic-assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer.
Rosenberg JE; Jung JH; Lee H; Lee S; Bakker CJ; Dahm P
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD013677. PubMed ID: 34365635
[TBL] [Abstract] [Full Text] [Related]
14. Third-line Life-prolonging Drug treatment in a Real-world Metastatic Castration-resistant prostate cancer Population: Results from the Dutch Castration-resistant prostate cancer Registry.
Notohardjo JCL; Kuppen MCP; Westgeest HM; van Moorselaar RJA; Mehra N; Coenen JLLM; van Oort IM; de Vos AI; Vervenne WL; van den Bergh ACM; Aben KKH; Somford DM; Bergman AM; Uyl-de Groot CA; Gerritsen WR; van den Eertwegh AJM
Eur Urol Focus; 2021 Jul; 7(4):788-796. PubMed ID: 32362484
[TBL] [Abstract] [Full Text] [Related]
15. Does urethral length affect continence outcomes following robot assisted laparoscopic radical prostatectomy (RALP)?
Lin D; O'Callaghan M; David R; Fuller A; Wells R; Sutherland P; Foreman D
BMC Urol; 2020 Jan; 20(1):8. PubMed ID: 32005113
[TBL] [Abstract] [Full Text] [Related]
16. Correlation of prostate-specific Antigen Kinetics with Overall Survival and Radiological Progression-free Survival in Metastatic Castration-sensitive prostate cancer Treated with Abiraterone Acetate plus Prednisone or Placebos Added to Androgen Deprivation Therapy: Post Hoc Analysis of Phase 3 LATITUDE Study.
Matsubara N; Chi KN; Özgüroğlu M; Rodriguez-Antolin A; Feyerabend S; Fein L; Alekseev BY; Sulur G; Protheroe A; Li S; Mundle S; De Porre P; Tran N; Fizazi K
Eur Urol; 2020 Apr; 77(4):494-500. PubMed ID: 31843335
[TBL] [Abstract] [Full Text] [Related]
17. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial.
Widmark A; Gunnlaugsson A; Beckman L; Thellenberg-Karlsson C; Hoyer M; Lagerlund M; Kindblom J; Ginman C; Johansson B; Björnlinger K; Seke M; Agrup M; Fransson P; Tavelin B; Norman D; Zackrisson B; Anderson H; Kjellén E; Franzén L; Nilsson P
Lancet; 2019 Aug; 394(10196):385-395. PubMed ID: 31227373
[TBL] [Abstract] [Full Text] [Related]
18. Oral bovine colostrum supplementation does not increase circulating insulin-like growth factor-1 concentration in healthy adults: results from short- and long-term administration studies.
Davison G; Jones AW; Marchbank T; Playford RJ
Eur J Nutr; 2020 Jun; 59(4):1473-1479. PubMed ID: 31123862
[TBL] [Abstract] [Full Text] [Related]
19. Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial.
Fizazi K; Tran N; Fein L; Matsubara N; Rodriguez-Antolin A; Alekseev BY; Özgüroğlu M; Ye D; Feyerabend S; Protheroe A; Sulur G; Luna Y; Li S; Mundle S; Chi KN
Lancet Oncol; 2019 May; 20(5):686-700. PubMed ID: 30987939
[TBL] [Abstract] [Full Text] [Related]
20. Outcomes of very high-risk prostate cancer after radical prostatectomy: Validation study from 3 centers.
Sundi D; Tosoian JJ; Nyame YA; Alam R; Achim M; Reichard CA; Li J; Wilkins L; Schwen Z; Han M; Davis JW; Klein EA; Schaeffer EM; Stephenson AJ; Ross AE; Chapin BF
Cancer; 2019 Feb; 125(3):391-397. PubMed ID: 30423193
[TBL] [Abstract] [Full Text] [Related]
[Next]
